Novartis vs AstraZeneca

Novartis leads AstraZeneca by 15.0 points on the Fameproof index, and wins 2 of the three models. Measured across 96 prompts per model per week.

Novartis
Novartis
Pharmaceuticals
31.5/100
Rank 56 on the companies board
AstraZeneca
AstraZeneca
Pharmaceuticals
16.5/100
Rank 76 on the companies board
Novartis
Per-model score
AstraZeneca
—
Claude
—
21.0
ChatGPT
14.0
42.0
Gemini
19.0
30-day movement
0.0
Change
+7.5
Last 7 runs
Answer quality
undefined%
Claude mention rate
undefined%
10%
ChatGPT mention rate
1%
38%
Gemini mention rate
8%
undefined%
Claude prominence
undefined%
4%
ChatGPT prominence
0%
15%
Gemini prominence
1%

Questions about this comparison

Who do AI models mention more, Novartis or AstraZeneca?

Novartis. It scores 31.5 on the Fameproof index against 16.5 for AstraZeneca — a lead of 15.0 points, measured across ChatGPT and Gemini in the run of 5 October 2026.

How is the Novartis vs AstraZeneca comparison measured?

Both are asked about with the same panel of category questions — never questions naming them — repeated on every model each week. The score combines how often each is named, how early in the answer, how much of the topic is covered and how consistent the result is.

Both are ranked on the Company AI Visibility board. Prominence reflects how early in an answer the model names them; mention rate is how often it names them at all. How the score is built.

Check my company